ST華鈺(601020.SH):道衡投資累計被動減持1.3611%股份
格隆匯7月7日丨ST華鈺(601020.SH)公佈,公司於2021年7月7日收到控股股東西藏道衡投資有限公司發來的《關於公司累計減持數量達到1%的吿知函》。其於2021年3月11日至2021年7月5日期間,通過上海證券交易所二級市場集中競價減持的方式,累計被動減持公司股份7,538,100股,被動減持比例為公司總股本的1.3611%。
此次權益變動後,道衡投資持有公司股份的比例由19.8887%減少至18.5276%。持股比例為持股數量佔目前公司總股本的比例。因公司“華鈺轉債”處於轉股期,總股本持續變化,截至2021年7月6日,公司總股本為553,811,610股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.